Article Details

Apreo Health secures $130 Million Series B funding to advance emphysema treatment trial

Retrieved on: 2025-08-07 15:21:19

Tags for this article:

Click the tags to see associated articles and topics

Apreo Health secures $130 Million Series B funding to advance emphysema treatment trial. View article details on hiswai:

Excerpt

Apreo Health, a clinical-stage medical device company developing a novel therapy for severe emphysema, has raised $130 million in an ...

Article found on: www.medicaleconomics.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo